
HSI Lunch Seminar Series Scale Up Event Series Part 2: Ramp Up
Details
HSI Lunch Seminar Series
Scale Up Event Series Part 2: Ramp Up
The Scale Up Event Series explores the concept of "scaling in healthcare", convening industry leaders who've successfully scaled healthcare solutions with strategic and financial investors. We delve into the challenges and opportunities of building thriving healthcare businesses at various stages.
The second event in the series, Ramp Up, focuses specifically on the crucial transition from startup to a sustainable business model.
Monday February 10, 2025
Location: E60-112
Access E60 from the cafe area of E62. Find the glass doors at the far right corner just before the staircase to enter building E60. Follow the hallway to room 112.
Time: 11:30am - 1pm
RSVP at Sloan Groups *Open to All*
Lunch will be provided in person.
Join Zoom Meeting
Speakers:
Financial Investor: Jason Slocum - Managing Director of Inclusive Growth, Goldman Sachs
Jason is a managing director in Sustainable Investing within Goldman Sachs Asset Management, leading the healthcare vertical within our Inclusive Growth strategy. He joined Goldman Sachs in 2024 as a managing director.
Previously, Jason served as a partner in the Healthcare Private Equity Group at Bain & Company, where he led deal diligence and portfolio company value creation initiatives with a wide range of healthcare-focused private equity funds.
He earned an AB in Economics and Government from Bowdoin College and an MBA, with high distinction, from Harvard Business School, where he was a Baker Scholar.
Strategic Investor: Gaye Bok
Partner | Artificial Intelligence and Digital Innovation Fund (AIDIF) · Mass General Brigham
Gaye leads Mass General Brigham’s $30M AI and Digital Innovation Venture Fund (AIDIF) investing in commercial stage digital health companies working with the Mass General Brigham system. Prior to joining Mass General Brigham, Gaye was a venture partner at an institutional venture fund where she was an integral part of the investment team and served as board director on several portfolio companies. Prior to venture investing, Gaye was an experienced commercial and business development executive, focused mainly on developing products and strategic partnerships across several verticals: chemicals, genomics, biobased energy and biobased products. Gaye received an MBA in Finance and International Management from MIT’s Sloan School and an AB from Harvard and Radcliffe Colleges.
Operator: Nell Buhlman, MBA
Chief Administrative Officer & Head of Strategy, PGForsta
Nell is a senior healthcare executive with 35 years of experience in data analytics and performance improvement. She currently serves as Chief Administrative Officer and Head of Strategy for PGForsta.
In her time with Press Ganey, Nell has held a range of roles—expanding her responsibilities as the company grew through acquisition and development. Prior to her current role, she served as Press Ganey’s President and Chief Operating Officer, overseeing day-to-day operations, product development, and research & analytics. Under Nell’s leadership, Press Ganey became the first in the industry to offer integrated analytics portraying the interplay of patient, caregiver, and business outcomes. She has authored numerous whitepapers on the value of an integrated data strategy in transforming the care experience for both patients and the healthcare workforce.
Nell serves as a board member and trustee at leading healthcare and charitable organizations, including Lifepoint Health and the Institute for Exceptional Care. She is an Executive in Residence at Johns Hopkins University Carey Business School.
Moderator: Kara Murphy
Kara is a Senior Partner and co-leader of the Global Healthcare Private Equity team.
She has over 20 years of healthcare and investing experience. She advises leading private equity investors and alternative asset managers across the full investment cycle. She has supported hundreds of due diligence assignments across the healthcare value chain. She has worked extensively with PE-backed portfolio companies on their value creation plans. Kara also supports investors on firm ambition, asset class strategy, fund operations, and fundraising.
Kara earned her MBA from Harvard Business School in 2001. She is also a graduate of Tufts University.
Co-Chairs:
Eric Berger, MBA '11, Partner, Bain & Company
Rebecca L. Schechter, MBA, Formerly at Nuance/Microsoft, Healthcare executive and CEO
Future Session:
MIT Sloan Lunch Seminar - Healthcare Talent Imperative
Tuesday March 4
Speakers:
Liam Hurley - Spencer Stuart
Anders Tveteraas - Novartis
Speakers

Gaye Bok
Partner, AI and Digital Innovation Fund
Mass General Brigham
https://www.linkedin.com/in/gaye-bok-309353/
Gaye leads Mass General Brigham’s $30M AI and Digital Innovation Venture Fund (AIDIF) investing in commercial stage digital health companies working with the Mass General Brigham system. Prior to joining Mass General Brigham, Gaye was a venture partner at an institutional venture fund where she was an integral part of the investment team and served as board director on several portfolio companies. Prior to venture investing, Gaye was an experienced commercial and business development executive, focused mainly on developing products and strategic partnerships across several verticals: chemicals, genomics, biobased energy and biobased products.
Gaye received an MBA in Finance and International Management from MIT’s Sloan School and an AB from Harvard and Radcliffe Colleges.

Nell Buhlman
Chief Administrative Officer & Head of Strategy
PG | Forsta
https://www.linkedin.com/in/nellwoodbuhlman/
Nell is a senior healthcare executive with 35 years of experience in data analytics and performance improvement. She currently serves as Chief Administrative Officer and Head of Strategy for PGForsta.
In her time with Press Ganey, Nell has held a range of roles—expanding her responsibilities as the company grew through acquisition and development. Prior to her current role, she served as Press Ganey’s President and Chief Operating Officer, overseeing day-to-day operations, product development, and research & analytics. Under Nell’s leadership, Press Ganey became the first in the industry to offer integrated analytics portraying the interplay of patient, caregiver, and business outcomes. She has authored numerous whitepapers on the value of an integrated data strategy in transforming the care experience for both patients and the healthcare workforce.
Nell serves as a board member and trustee at leading healthcare and charitable organizations, including Lifepoint Health and the Institute for Exceptional Care. She is an Executive in Residence at Johns Hopkins University Carey Business School.

Jason Slocum
Managing Director of Inclusive Growth, Goldman Sachs
Goldman Sachs
https://www.linkedin.com/in/jason-slocum-436a6011/
Jason is a managing director in Sustainable Investing within Goldman Sachs Asset Management, leading the healthcare vertical within our Inclusive Growth strategy. He joined Goldman Sachs in 2024 as a managing director.
Previously, Jason served as a partner in the Healthcare Private Equity Group at Bain & Company, where he led deal diligence and portfolio company value creation initiatives with a wide range of healthcare-focused private equity funds.
He earned an AB in Economics and Government from Bowdoin College and an MBA, with high distinction, from Harvard Business School, where he was a Baker Scholar.

Kara Murphy
Partner
Partner, Bain & Company
https://www.linkedin.com/in/kara-murphy-36a790/
Kara is a Senior Partner and co-leader of our Global Healthcare Private Equity team.
She has over 20 years of healthcare and investing experience. She advises leading private equity investors and alternative asset managers across the full investment cycle. She has supported hundreds of due diligence assignments across the healthcare value chain. She has worked extensively with PE-backed portfolio companies on their value creation plans. Kara also supports investors on firm ambition, asset class strategy, fund operations, and fundraising.
Kara earned her MBA from Harvard Business School in 2001. She is also a graduate of Tufts University.

Eric Berger
Partner
Bain & Company
https://www.linkedin.com/in/eric-berger-48367215/
Eric Berger is a member of Bain’s Healthcare & Life Sciences and Private Equity practices with more than 10 years of consulting experience.
Eric advises clients across a range of industries, with a focus in private equity funds as well as healthcare payers and services and biotech / pharma. He has additional experience in industrial goods and services and consumer packaged goods.
He holds expertise in topics related to commercial due diligence, business unit strategy, operating model, organization design, pricing, brand strategy and mergers & acquisitions.
Prior to joining Bain in 2011, Eric worked for a small consulting firm in Boston focused on the pharmaceutical, biotech and medical device industries. Previously, he was a researcher in organic chemistry at Harvard University. Eric has published in Science and the Journal of the American Chemical Society and was awarded a grant from the Howard Hughes Medical Institute and the Jean Dreyfus Boissevain scholarship.
Eric earned an MBA from MIT Sloan School of Management. He holds a BA cum laude and MA in chemistry from Harvard University.

Rebecca L. Schechter, MBA
Healthcare executive and CEO
Formerly at Nuance/Microsoft
https://www.linkedin.com/in/rebecca-schechter/
With over 25 years of experience in building and transforming businesses at scale across healthcare and financial services, she is a passionate end to end P&L leader/CEO having led business with revenue of $250M to $6B., investor, and advisor who leverages technology to improve outcomes for all.
Most recently, as the SVP and General Manager of DAX, Nuance's market-leading healthcare GenAI SaaS solution, she led a team of talented professionals committed to transforming the clinician-patient experience with the latest advancements in conversational AI, ambient intelligence, and generative AI. Prior to that, she was the CEO of Optum Behavioral Health and held President and C-Suite roles at Liberty Mutual and State Street.
She is a Board Director at iA Financial Group, where she contributes to the risk, governance, and ethics oversight of one of Canada's largest insurance and wealth management companies. As a Venture Partner at Nina Capital, a global healthtech venture fund, she supports early-stage startups that are developing cutting-edge solutions in digital health, medtech, biotech, and wellness. She is also an advisor to global Private Equity Investors in healthcare/technology.
Her core competencies include driving transformative plays at scale, delivering profitable growth with a proven track record in highly competitive and regulated markets. She has an MBA from MIT Sloan, and has lived, worked and studied across Europe, North America and Asia.

Anne Quaadgras
Director
MIT Sloan Health Systems Initiative
https://www.linkedin.com/in/anne-quaadgras-6208778/
Anne Quaadgras is the Director of the MIT Sloan Health Systems Initiative and a Senior Lecturer at MIT Sloan.
Her work focuses on health systems transformation, and the role of information technology in supporting that change.
Prior to her doctoral work, Anne was a management consultant for fifteen years, specializing in improving decision-making and investment processes in the chemical, pharmaceutical, and financial services industries.
She holds a Bachelor’s and Master’s degree in chemical engineering from MIT. Anne earned her doctorate in information systems at Boston University, where her dissertation research explored how globally distributed groups of experts recognize and respond to operational problems.